China Resources Pharmaceutical Group
3320.HK
$0.67
Share price
2.96%
Change (1 day)
-32.32%
Change (1 year)
Categories
Revenue for China Resources Pharmaceutical Group (3320.HK)
Revenue in 2022: $32.58 B
According to China Resources Pharmaceutical Group's latest financial reports the company's current revenue (TTM
) is $32.58 B.
In 2022 the company made a revenue of $32.58 B an increase over the years 2021 revenue that were of $30.36 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for China Resources Pharmaceutical Group from 2013 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 | $32.58 B | 7.28% |
| 2021 | $30.36 B | 17.47% |
| 2020 | $25.85 B | -1.52% |
| 2019 | $26.25 B | 8.38% |
| 2018 | $24.22 B | 9.7% |
| 2017 | $22.08 B | 9.27% |
| 2016 | $20.20 B | 6.86% |
| 2015 | $18.91 B | 8.05% |
| 2014 | $17.50 B | 16.04% |
| 2013 | $15.08 B |